ME/CFS Through the Lens of Universal Disease Mechanisms

Most diseases do not invent new biology — they dysregulate mechanisms that are shared across the entire spectrum of human pathology. The body can respond to injury, infection, or metabolic insult in only a finite number of ways (Ayres 2020) (Quintero 2014). This observation, recurring across network medicine, systems pathobiology, and medical education reform proposals, suggests that the ~17,000 named diagnostic categories in ICD-11 are not 17,000 independent phenomena, but rather different combinatorial expressions of a much smaller set of fundamental mechanism families — roughly 20 in total — each instantiated in different tissues, at different severities, and triggered by different initiating events.

This chapter provides a systematic survey of those mechanism families and assesses where ME/CFS stands within each. The taxonomy is built inductively from the pathophysiology literature — no single published framework covers all of them at this specificity — and represents the paper’s own synthesis. For each family we enumerate the concrete mechanisms within it, assess the state of ME/CFS-specific evidence, and cross-reference the dedicated chapter where the evidence is treated in depth.

The goals are twofold. First, completeness: ensuring the paper does not inadvertently ignore a mechanism family simply because it has attracted little ME/CFS-specific research attention. Second, positioning: situating ME/CFS within the broader disease landscape, which is essential for the cross-disease comparisons in Speculative Mechanistic Hypotheses and for the research gap agenda in Entries added 2026-08-26: Central Motor-Drive Fatigability Cascade (Bedard 2026).

The 19 universal disease mechanism families and ME/CFS evidence status. Evidence levels follow Evidence Level Classification. Order does not imply causal priority.
# Family Evidence in ME/CFS Status
1 Energy and metabolic regulation Mitochondrial OXPHOS; PDH/PDK block; NAD⁺ Established
2 Redox and oxidative balance ROS, nitrosative stress, lipid peroxidation Established
3 Ion channel and membrane transport TRPM3 channelopathy; RBC membrane stiffness Established
4 Immune activation and cytokine signalling NK exhaustion; cytokine excess; complement Established
5 Autoimmunity and molecular mimicry Anti-β2AR; anti-M3R; anti-TRPM3 Established
6 Coagulation and haematological Fibrin microclots; platelet hyperactivation Probable
7 Vascular and endothelial Endothelial dysfunction; cerebral hypoperfusion Established
8 Autonomic and peripheral nervous system Baroreflex failure; POTS; small fiber neuropathy Established
9 Neuroendocrine and hormonal HPA blunting; low T3; sex hormone dysregulation Probable
10 Neurological and thalamocortical Neuroinflammation; E/I imbalance; alpha intrusion Established
11 Amino acid and neurotransmitter metabolism Tryptophan/IDO/kynurenine; serotonin depletion Probable
12 Genomic and epigenetic regulation Methylation signatures; telomere attrition Established
13 Protein homeostasis and degradation HSP dysregulation; autophagy block (ATG13) Emerging
14 Cell death and senescence NK/T cell exhaustion; immunosenescence; SASP Emerging
15 Gut-microbiome-immune axis Dysbiosis; leaky gut; LPS translocation Probable
16 Viral persistence and immune evasion EBV/HHV-6 reactivation; enterovirus persistence Probable
17 Structural and tissue integrity Skeletal muscle damage; SFN fiber loss; hEDS overlap Emerging
18 Transcriptional and nuclear signalling NF-κB (inferred); Nrf2 (indirect); VDR Theoretical
19 Purinergic and danger signalling ATP-DAMP/P2X7; CDR hypothesis; NLRP3 (unstudied) Theoretical
NoteChapter Roadmap: How to Use This Chapter

For patients: read the overview table to see the breadth of affected mechanisms and the family sections relevant to your symptoms (e.g., energy, immune, vascular). Each family cross-references its full chapter.

For caregivers: read the overview table for a one-page map of the disease’s systems. Individual family detail is best accessed via the cross-referenced chapters.

For clinicians: use the overview table and each family’s evidence-status line as a rapid reference; the cross-references route to the in-depth chapter for each mechanism.

For researchers: read the full family sections for completeness — the emerging/theoretical families (protein homeostasis, cell death, purinergic) flag the least-studied mechanisms and the research-gap agenda feeding Chapter Entries added 2026-08-26: Central Motor-Drive Fatigability Cascade (Bedard 2026).

1 Contents

References

Ayres, Janelle S. 2020. “The Biology of Physiological Health.” Cell 181 (2): 250–69. https://doi.org/10.1016/j.cell.2020.03.029.
Quintero, Guillermo A. 2014. “Medical Education and the Healthcare System — Why Does the Curriculum Need to Be Reformed?” BMC Medicine 12: 213. https://doi.org/10.1186/s12916-014-0213-3.